Abstract
Cancer is a disease of significant global burden, characterized by the uncontrolled growth of cells with the capacity for invasion and metastasis. Its origin is linked to genetic and epigenetic alterations that disrupt the balance between proto-oncogenes and tumor suppressor genes, enabling autonomous cell proliferation and clonal evolution toward more aggressive phenotypes. During this process, cells acquire properties known as the hallmarks of cancer, which explain its progression and therapeutic resistance.
Pathology is the cornerstone discipline in oncologic diagnosis. Through histological, cytological, immunohistochemical, and molecular assessments, it enables the identification of tumor type, its degree of differentiation, invasiveness, and characteristics with therapeutic potential. Tools such as immunohistochemistry, genomic sequencing, and liquid biopsy have expanded diagnostic, prognostic, and personalized therapeutic possibilities.
Tumors are classified according to their cellular lineage and biological behavior as benign or malignant. Benign tumors exhibit slow growth, are well circumscribed, and do not metastasize. Malignant tumors, on the other hand, display anaplasia, local invasion, and distant dissemination. Understanding key terms such as differentiation, dysplasia, carcinoma in situ, invasion, and metastasis is fundamental for appropriately interpreting pathological findings.
From a clinical perspective, the general practitioner plays a crucial role in early detection, initial interpretation of warning signs, and timely referral. Moreover, they should understand the basic principles of modern oncology to effectively support the diagnostic and therapeutic process. Strengthening these competencies at the primary care level is essential to improve access, treatment quality, and health outcomes for cancer patients.
References
Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12(1):31-46. doi:10.1158/2159-8290.CD-21-1059
Kumar V, Abbas AK, Aster JC. Patología estructural y funcional de Robbins. 9.ª ed. Elsevier; 2024.
Goldblum JR, Lamps LW, McKenney JK. Rosai and Ackerman's Surgical Pathology. 11th ed. 2 vols. Philadelphia: Elsevier; 2017. ISBN: 9780323263399.
WHO Classification of Tumours Editorial Board. WHO Classification of Tumours Online. Lyon: International Agency for Research on Cancer; 2022. Disponible en: https://tumourclassification.iarc.who.int/
International Agency for Research on Cancer. Global Cancer Observatory. Lyon: World Health Organization; 2022. Disponible en: https://gco.iarc.fr/en
Cuenta de Alto Costo. Día Mundial de la Lucha contra el Cáncer de Mama 2023 [Internet]. Bogotá: Cuenta de Alto Costo; 2023. Disponible en: https://cuentadealtocosto.org/cancer/dia-mundial-de-la-lucha-contra-el-cancer-de-mama-2023.
McPherson RA, Pincus MR. Henry's Clinical Diagnosis and Management by Laboratory Methods. 24th ed. Philadelphia: Elsevier; 2021. ISBN: 9780323673204.
Kiri S, Ryba T. Cancer, metastasis, and the epigenome. Mol Cancer. 2024;23(1):154. Published 2024 Aug 2. doi:10.1186/s12943-024-02069-w
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-249. doi:10.3322/caac.21660
Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127(16):3029-3030. doi:10.1002/cncr.33587
Bertram JS. The molecular biology of cancer. Mol Aspects Med. 2000;21(6):167-223. doi:10.1016/s0098-2997(00)00007-8
Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759-767. doi:10.1016/0092-8674(90)90186-i
Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science. 2013;339(6127):1546-1558. doi:10.1126/science.1235122
Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature. 2009;458(7239):719-724. doi:10.1038/nature07943
Weinberg, R., & Cell, O. R. (2017). The Principles and Drivers of Cancer. The American Cancer Society's Principles of Oncology: Prevention to Survivorship, 139.
Ecsedy, J. E. F. F. R. E. Y., & Hunter, D. A. V. I. D. (2002). The origin of cancer. Textbook of cancer epidemiology, 3, 61-85.
Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours. 8th ed. Wiley-Blackwell; 2017.
Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin. 2017;67(2):93-99. doi:10.3322/caac.21388
Pineros M, Abriata MG, de Vries E, Barrios E, Bravo LE, Cueva P, et al. Progress, challenges and ways forward supporting cancer surveillance in Latin America. Int J Cancer 2021;149:12–20.
Greaves M. Evolutionary determinants of cancer. Cancer Discov. 2015;5(8):806-820. doi:10.1158/2159-8290.CD-15-0439
Gerlinger M, McGranahan N, Dewhurst SM, Burrell RA, Tomlinson I, Swanton C. Cancer: evolution within a lifetime. Annu Rev Genet. 2014;48:215-236. doi:10.1146/annurev-genet-120213-092314
Bremnes RM, Dønnem T, Al-Saad S, et al. The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer. J Thorac Oncol. 2011;6(1):209-217. doi:10.1097/JTO.0b013e3181f8a1bd
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin 2022;72:7–33.
Schwartz SM. Epidemiology of Cancer. Clin Chem. 2024;70(1):140-149. doi:10.1093/clinchem/hvad202.
Moni ZA, Hasan Z, Alam MS, Roy N, Islam F. Diagnostic and Prognostic Significance of Exosomes and Their Components in Patients With Cancers. Cancer Med. 2025;14(1):e70569. doi:10.1002/cam4.70569
